FMP
OptimizeRx Reaffirms 2023 Guidance
May 25, 2023 5:00 PM - Davit Kirakosyan
Image credit: FMP
OptimizeRx Corporation (NASDAQ:OPRX) reaffirmed its 2023 over 10% revenue growth outlook, provided a positive update concerning the visibility it now has into achieving that target, and also introduced longer-term goals of reaching $100-120 million revenue and 20% EBITDA margin within the next 18-24 months.
Underpinning its confidence in the latter, management cites strong macro tailwinds, expanded offerings and strengthening commercial momentum.
Analysts at RBC Capital find all these encouraging but also noted growth thus far has been choppy, and absent M&A, achieving even the low end of the long-term revenue target would require a meaningful multi-year acceleration from 2022 and 2023 levels.
Other Blogs
Sep 11, 2023 1:38 PM - Rajnish Katharotiya
P/E Ratios Using Normalized Earnings
Price to Earnings is one of the key metrics use to value companies using multiples. The P/E ratio and other multiples are relative valuation metrics and they cannot be looked at in isolation. One of the problems with the P/E metric is the fact that if we are in the peak of a business cycle, earni...
Sep 11, 2023 1:49 PM - Rajnish Katharotiya
What is Price To Earnings Ratio and How to Calculate it using Python
Price-to-Earnings ratio is a relative valuation tool. It is used by investors to find great companies at low prices. In this post, we will build a Python script to calculate Price Earnings Ratio for comparable companies. Photo by Skitterphoto on Pexels Price Earnings Ratio and Comparable Compa...
Oct 17, 2023 3:09 PM - Davit Kirakosyan
VMware Stock Drops 12% as China May Hold Up the Broadcom Acquisition
Shares of VMware (NYSE:VMW) witnessed a sharp drop of 12% intra-day today due to rising concerns about China's review of the company's significant sale deal to Broadcom. Consequently, Broadcom's shares also saw a dip of around 4%. Even though there aren’t any apparent problems with the proposed solu...
